Esprit BTK Drug-Eluting Resorbable Scaffold vs. Angioplasty for Below-Knee Arterial Disease: The LIFE-BTK Trial

Esprit BTK Drug-Eluting Resorbable Scaffold vs. Angioplasty for Below-Knee Arterial Disease: The LIFE-BTK Trial

According to the LIFE-BTK trial, the Esprit BTK everolimus-eluting resorbable scaffold (DRS) had superior 1-year efficacy compared with balloon angioplasty in patients with comprehensive severe chronic lower limb ischemia (CLTI) with below-knee arterial disease. Dr. Ramon L. Varcoe, Prince of Wales Hospital, Australia, presented in the Late-Breaking Clinical Trials session of TCT 2023.

Promising results for DRS for below-knee lesions were reported in the ABSORB BTK trial, and the Espr...
Continue reading this article
Select an option below:
Go beyond the guidelines
A portal site of complex catheter intervention techniques
About TCROSS NEWS Global

TCROSS NEWS Global is an online medical journal that provides valuable information on Cardiovascular medicine to medical professionals worldwide.
We bring you the latest findings and trends in all areas of cardiovascular medicine. Please register and subscribe for unlimited access to quality Cardiovascular News!

Introducing the main contents
Conference Reports
Conference Reports
Timely delivery of scientific meetings from around the world, including AHA, ESC, TCT, EuroPCR, JCC, etc!
Complex PCI Cases
Complex PCI Cases
Features case reports on patients with complex lesions encountered in daily clinical practice.
Live Demonstration Courses
Live Demonstration CoursesComing soon
In this section you will find live videos of catheter interventions for complex lesions.
What is TCROSS NEWS GLOBAL?
TCROSS NEWS Global, an affiliate of TCROSS Co., Ltd. Japan(established in 2005) is a cardiovascular news website which serves as a link between cardiologists, medical device manufacturers and industry stakeholders.
We provide timely and up-to-date information to our partners across the world by covering and reporting live sessions and conferences, featuring of complex cases, newsletters, academic researches and case studies.
Learn more about TCROSS NEWS Global
This website is automatically translated using Google Translate.

Recommendations

Standard Balloon vs. Agent Paclitaxel-Coated Balloon for In-Stent Restenosis of Coronary Arteries: The AGENT IDE Trial
Standard Balloon vs. Agent Paclitaxel-Coated Balloon for In-Stent Restenosis of Coronary Arteries: The AGENT IDE Trial
TCT 2023
TAVR with Sapien 3 in Low-Risk Patients: 5-Year Follow-up of the PARTNER 3 Trial
TAVR with Sapien 3 in Low-Risk Patients: 5-Year Follow-up of the PARTNER 3 Trial
TCT 2023
TAVR with Self-Expandable Devices in Low-Risk Patients: 4-Year Follow-up of the EVOLUT Low Risk Trial
TAVR with Self-Expandable Devices in Low-Risk Patients: 4-Year Follow-up of the EVOLUT Low Risk Trial
TCT 2023
OCT-Guided vs. Angiography-Guided PCI: The COCOA Study
OCT-Guided vs. Angiography-Guided PCI: The COCOA Study
TCT 2023
PICK UP
Challenging Healthcare Marketing Costs toward Achieving Universal Health Coverage
Special
InsighTCROSS
Optimal IVUS-Guided LM-PCI: The OPTIVUS-Complex PCI Study LMCA Cohort
AJC
Optimal IVUS-Guided LM-PCI: The OPTIVUS-Complex PCI Study LMCA Cohort
Comparison of Limus and Paclitaxel Drug-Coated Balloons, Second-Generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials
Circ Intervention
Comparison of Limus and Paclitaxel Drug-Coated Balloons, Second-Generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled Trials
Predictors of Cardiovascular Events After Coronary IVL Use: The BENELUX-IVL Registry
AJC
Predictors of Cardiovascular Events After Coronary IVL Use: The BENELUX-IVL Registry
Orbital Atherectomy vs Balloon-Based Vessel Preparation for Severely Calcified Coronary Lesions: The ECLIPSE OCT Substudy
Circ Intervention
Orbital Atherectomy vs Balloon-Based Vessel Preparation for Severely Calcified Coronary Lesions: The ECLIPSE OCT Substudy